Patents by Inventor Alex Stenzler

Alex Stenzler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8490622
    Abstract: A respiratory apparatus including an adapter assembly and a catheter assembly. The adapter assembly includes ventilator, respiratory, access, and flush ports. The access port includes a conduit defining a passageway. The flush port projects from the conduit and is fluidly open to the passageway at an outlet. The catheter assembly includes a catheter assembled to a fitting. The fitting includes a hub and a tube, with the tube defining an exterior surface, an interior surface forming a lumen, a circumferential groove in the exterior surface, and a plurality of apertures fluidly open to the lumen and the circumferential groove. The tube is sized to be slidably received within the passageway such that upon final assembly, a fluid pathway is formed between the flush port and a distal end of the catheter via the flush port outlet, the circumferential groove, the plurality of apertures, and the lumen.
    Type: Grant
    Filed: July 29, 2009
    Date of Patent: July 23, 2013
    Assignee: CareFusion 207, Inc.
    Inventors: Alex Stenzler, Steve Han, David Matthew Young
  • Publication number: 20130152929
    Abstract: A system for keeping moisture in a vapor phase and for removing particles from a gas is described. The system includes a filter and a heating chamber. The filter is capable of being heated and includes a mechanical element that effectively regulates the heating of the filter. Heat production of the heating chamber is coupled to the proper insertion of the filter into the chamber, such that the filter closes an electrical switch in the heating chamber to allow for the production of heat. An exemplary use of the system is the keeping moisture in a vapor phase and removing pathogenic particles from the exhalation path of a ventilated subject.
    Type: Application
    Filed: December 16, 2011
    Publication date: June 20, 2013
    Inventors: Alex Stenzler, Steve Han
  • Patent number: 8394030
    Abstract: The present invention includes an apparatus and a method for testing exhaled breath condensate for at least one biometric marker, including a substrate for collecting exhaled breath condensate, the substrate capable of being brought to a temperature below a dew point of vapor in exhaled breath, a collector for retaining the substrate and for receiving a biometric marker reagent. The invention may further include receiving exhaled breath in a collector, the collector comprising a substrate, the substrate being at a temperature below a dew point of vapor in exhaled breath, collecting the exhaled breath condensate on the substrate, and bringing a biometric marker reagent in contact with the substrate.
    Type: Grant
    Filed: March 18, 2009
    Date of Patent: March 12, 2013
    Assignee: CareFusion 207, Inc.
    Inventors: Christopher Varga, Alex Stenzler
  • Publication number: 20120247460
    Abstract: A metered dose inhaler (MDI) spacer has a body that defines a dose receiving chamber. A proximal end portion coupled between the body and a mouth port through which a metered dose may be inhaled by a user of the MDI spacer. A distal end portion is coupled with the body. A combined one-way and flow rate control valve coupled with the distal end portion is configured for permitting external airflow into and prohibiting internal airflow out of the dose receiving chamber. A collar coupled with the distal end portion is configured for receiving an actuator shaft of a metered dose inhaler and for forming a seal about an aerosol nozzle of the metered dose inhaler such that a metered dose of medication is admissible into the dose receiving chamber via the collar while airflow into and out of the dose receiving chamber via the collar is prohibited.
    Type: Application
    Filed: March 31, 2011
    Publication date: October 4, 2012
    Inventors: Alex STENZLER, Steve HAN
  • Publication number: 20120199123
    Abstract: A method and corresponding device are described for combating microbes and infections by delivering intermittent high doses of nitric oxide to a mammal for a period of time and which cycles between high and low concentration of nitric oxide gas. The high concentration of nitric oxide is preferably delivered intermittently for brief periods of time that are interspersed with periods of time with either no nitric oxide delivery or lower concentrations of nitric oxide. The method is advantageous because at higher concentration, nitric oxide gas overwhelms the defense mechanism of pathogens that use the mammalian body to replenish their thiol defense system. A lower dose or concentration of nitric oxide gas delivered in between the bursts of high concentration nitric oxide maintains nitrosative stress pressure on the pathogens and also reduces the risk of toxicity of nitric oxide gas.
    Type: Application
    Filed: February 8, 2012
    Publication date: August 9, 2012
    Applicants: PULMONOX TECHNOLOGIES CORPORATION, SENSORMEDICS CORPORATION
    Inventors: Alex STENZLER, Chris MILLER, Bevin B. MCMULLIN
  • Patent number: 8231606
    Abstract: A minimally invasive tracheal fluid removal device and corresponding method of use for removing accumulated subglottic secretions in an intubated patient's endotracheal tube. The device may be configured as a dual-track or single-tube suction guidance system. This device presents a significant improvement over the art as it eliminates the need to reintubate the patient each time the suction mechanism is removed to be cleaned.
    Type: Grant
    Filed: March 14, 2008
    Date of Patent: July 31, 2012
    Assignee: CareFusion 207, Inc.
    Inventors: Alex Stenzler, David Matthew Young
  • Patent number: 8100125
    Abstract: Provided is a universal interface adapted for providing continuous positive airway pressure to a patient when the interface is used with a standard ventilator. The interface is configured to operate at a supply pressure no greater than about 120 centimeters of H2O in order to deliver pressure to the patient of up to about 15 cm of H2O at a flow rate of up to about 12 liters/minute. The universal interface may comprise an interface body having a space pair of breathing passageways intersecting a corresponding of supply passageways. Each one of the breathing passageways is comprised of a patient passageway and an exhalation passageway. Each one of the supply passageways includes a jet venturi having a taper portion. Each one of the exhalation passageways includes a taper portion which tapers outwardly along a direction from the patient passageway toward the exhalation passageway.
    Type: Grant
    Filed: September 30, 2005
    Date of Patent: January 24, 2012
    Assignee: CareFusion 207, Inc.
    Inventors: Steven Duquette, Alex Stenzler, Steve Han
  • Patent number: 8043252
    Abstract: A method of topically treating the respiratory tract of a mammal with nitric oxide exposure includes the steps of providing a source of nitric oxide containing gas and delivering the nitric oxide containing gas nasally to the upper respiratory tract of the mammal. Also provided are several designs for a nasal delivery device for the controlled nasal deliver the nitric oxide containing gas.
    Type: Grant
    Filed: December 20, 2007
    Date of Patent: October 25, 2011
    Assignees: Sensormedics Corporation, Pulmonox Technologies Corporation
    Inventors: Christopher Miller, Alex Stenzler
  • Publication number: 20110245759
    Abstract: The present invention provides methods of treating bacterial, viral, protozoan, parasitic, arthropod and fungal infections by applying gaseous nitric oxide to a patient having an infection. The present invention further provides improved methods of treating bacterial, viral, protozoan, parasitic and fungal infections by applying gaseous nitric oxide, in combination with oxygen, to a patient having an infection.
    Type: Application
    Filed: July 30, 2009
    Publication date: October 6, 2011
    Inventors: Frank J. McCaney, Alex Stenzler
  • Publication number: 20110226241
    Abstract: A method and corresponding device are described for combating microbes and infections by delivering intermittent high doses of nitric oxide to a mammal for a period of time and which cycles between high and low concentration of nitric oxide gas. The high concentration of nitric oxide is preferably delivered intermittently for brief periods of time that are interspersed with periods of time with either no nitric oxide delivery or lower concentrations of nitric oxide. The method is advantageous because at higher concentration, nitric oxide gas overwhelms the defense mechanism of pathogens that use the mammalian body to replenish their thiol defense system. A lower dose or concentration of nitric oxide gas delivered in between the bursts of high concentration nitric oxide maintains nitrosative stress pressure on the pathogens and also reduces the risk of toxicity of nitric oxide gas.
    Type: Application
    Filed: January 14, 2011
    Publication date: September 22, 2011
    Applicants: SENSORMEDICS CORPORATION, PULMONOX TECHNOLOGIES CORPORATION
    Inventors: Alex STENZLER, Chris Miller, Bevin B. McMullin
  • Patent number: 7955294
    Abstract: A method and corresponding device are described for combating microbes and infections by delivering intermittent high doses of nitric oxide to a mammal for a period of time and which cycles between high and low concentration of nitric oxide gas. The high concentration of nitric oxide is preferably delivered intermittently for brief periods of time that are interspersed with periods of time with either no nitric oxide delivery or lower concentrations of nitric oxide. The method is advantageous because at higher concentration, nitric oxide gas overwhelms the defense mechanism of pathogens that use the mammalian body to replenish their thiol defense system. A lower dose or concentration of nitric oxide gas delivered in between the bursts of high concentration nitric oxide maintains nitrosative stress pressure on the pathogens and also reduces the risk of toxicity of nitric oxide gas.
    Type: Grant
    Filed: November 10, 2006
    Date of Patent: June 7, 2011
    Assignees: Sensormedics Corporation, Pulmonox Technologies Corporation
    Inventors: Alex Stenzler, Christopher C. Miller, Bevin B. McMullin
  • Publication number: 20110112468
    Abstract: Topical exposure of nitric oxide gas to wounds such as chronic non-healing wounds may be beneficial in promoting healing of the wound and in preparing the wound bed for further treatment and recovery. Nitric oxide gas may be used, for example, to reduce the microbial infection and burden on these wounds, manage exudate secretion by reducing inflammation, upregulate expression of endogenous collagenase to locally debride the wound, and regulate the formation of collagen. High concentration of nitric oxide ranging from about 160 to 400 ppm may be used without inducing toxicity in the healthy cells around a wound site. Additionally, exposure to the high concentration for a first treatment period reduces the microbial burden and inflammation at the wound site and increase collagenase expression to debride necrotic tissue at the wound site.
    Type: Application
    Filed: January 13, 2011
    Publication date: May 12, 2011
    Applicants: SENSORMEDICS CORPORATION, PULMONOX TECHNOLOGIES CORPORATION
    Inventors: Alex STENZLER, Christopher C. MILLER
  • Patent number: 7892198
    Abstract: A device for the topical delivery of nitric oxide gas to an infected area of skin includes a source of nitric oxide gas, a bathing unit, a flow control valve, and a vacuum unit. The bathing unit is adapted to surround the area of the infected skin and form a substantially air-tight seal with the skin surface. The bathing unit is also in fluidic communication with the source of nitric oxide. The flow control valve is position downstream of the source of nitric oxide and upstream of the bathing unit. The flow control valve controls the amount of nitric oxide gas that is delivered to the bathing unit. The vacuum unit is positioned downstream of the bathing unit and is used to withdraw gas from the bathing unit. Application of nitric oxide gas to the infected area of skin reduces levels of bacteria in the infected area and promotes the healing process.
    Type: Grant
    Filed: September 17, 2004
    Date of Patent: February 22, 2011
    Assignee: Sensormedics Corporation
    Inventor: Alex Stenzler
  • Publication number: 20100241019
    Abstract: The present invention includes an apparatus and a method for testing exhaled breath condensate for at least one biometric marker, including a substrate for collecting exhaled breath condensate, the substrate capable of being brought to a temperature below a dew point of vapor in exhaled breath, a collector for retaining the substrate and for receiving a biometric marker reagent. The invention may further include receiving exhaled breath in a collector, the collector comprising a substrate, the substrate being at a temperature below a dew point of vapor in exhaled breath, collecting the exhaled breath condensate on the substrate, and bringing a biometric marker reagent in contact with the substrate.
    Type: Application
    Filed: March 18, 2009
    Publication date: September 23, 2010
    Applicant: Cardinal Health 207, Inc.
    Inventors: Christopher Varga, Alex Stenzler
  • Publication number: 20100206309
    Abstract: A gas flow regulating device including a housing assembly, an inlet tube assembly, and a biasing device. The housing assembly has a main housing, a valve seat body, and a distal plate forming an outlet orifice. The inlet tube assembly includes a proximal inlet end, a tube forming a lumen, and a flange, and is slidably disposed within the main housing, biased to an open state by the biasing device. The flange separates middle and constant pressure chambers within the housing assembly. The inlet tube assembly is transitionable to a closed state in response to pressure in the constant pressure chamber to generate a relatively constant flow rate of air exiting the device via the outlet orifice.
    Type: Application
    Filed: February 17, 2009
    Publication date: August 19, 2010
    Applicant: CARDINAL HEALTH 207, INC.
    Inventors: Steve Han, Alex Stenzler
  • Publication number: 20100174210
    Abstract: A fluid flow control apparatus used in medical fluid sampling. The apparatus includes a valve assembly, first and second ports, and a cap. The valve assembly comprises a body rotatably assembled to a housing and defining a passageway and at least two recesses defined by an interior surface of the housing and the body which is formed separate from the passageway. The ports extend from the housing and are configured for connection to medical devices. The valve assembly is operable to interchangeably align the passageway and the recesses with the ports. Finally, the cap is connected to the housing, and forms an opening for coupling to a specimen container.
    Type: Application
    Filed: January 6, 2009
    Publication date: July 8, 2010
    Applicant: ALLEGIANCE CORPORATION
    Inventors: Steve Han, Alex Stenzler
  • Publication number: 20100024823
    Abstract: An adapter assembly including a manifold and a valve assembly. The valve assembly includes a seat and a valve body having a circular base and a wall. The wall extends from a trailing side of the base to form a dome-like shape terminating at an end at which a slit is formed, with the wall defining opposing sealing edges at the slit. The seat has an upper circumferential surface and a lower circumferential surface. The upper surface engages a leading side of the base, whereas the lower surface engages a trailing side. At least one of the upper and lower surfaces forms a segment of increased height. Upon final assembly, the valve body is disposed across a passageway of the manifold, with the slit providing a selectively openable path. A force imparted by the segment of increased height flexes the base and biases the sealing edges into engagement.
    Type: Application
    Filed: July 29, 2009
    Publication date: February 4, 2010
    Inventors: Alex Stenzler, Steve Han
  • Publication number: 20100024818
    Abstract: A respiratory apparatus including an adapter assembly and a catheter assembly. The adapter assembly includes ventilator, respiratory, access, and flush ports. The access port includes a conduit defining a passageway. The flush port projects from the conduit and is fluidly open to the passageway at an outlet. The catheter assembly includes a catheter assembled to a fitting. The fitting includes a hub and a tube, with the tube defining an exterior surface, an interior surface forming a lumen, a circumferential groove in the exterior surface, and a plurality of apertures fluidly open to the lumen and the circumferential groove. The tube is sized to be slidably received within the passageway such that upon final assembly, a fluid pathway is formed between the flush port and a distal end of the catheter via the flush port outlet, the circumferential groove, the plurality of apertures, and the lumen.
    Type: Application
    Filed: July 29, 2009
    Publication date: February 4, 2010
    Inventors: Alex Stenzler, Steve Han, David Matthew Young
  • Publication number: 20090229615
    Abstract: A minimally invasive tracheal fluid removal device and corresponding method of use for removing accumulated subglottic secretions in an intubated patient's endotracheal tube. The device may be configured as a dual-track or single-tube suction guidance system. This device presents a significant improvement over the art as it eliminates the need to reintubate the patient each time the suction mechanism is removed to be cleaned.
    Type: Application
    Filed: March 14, 2008
    Publication date: September 17, 2009
    Inventors: Alex STENZLER, David Matthew YOUNG
  • Publication number: 20090107497
    Abstract: A respiratory assist device and method for the prevention of ventilator acquired pneumonia in a patient is described. The respiratory assist device administers nitric oxide to the oropharyngeal area in order to decontaminate or prevent the contamination of secretions that collect in the oropharyngeal area during intubation of the patient. The respiratory assist device and method may be adapted for use, for example, as an endotracheal tube or as a tracheotomy tube.
    Type: Application
    Filed: October 29, 2007
    Publication date: April 30, 2009
    Inventors: Alex Stenzler, Arthur S. Slutsky